Notice: Applications, Hearings, Determinations, Etc.: Noramco Inc.

Federal Register / Vol. 72, No.
96 / Friday, May 18, 2007 / Notices 28075
No comments or objections have been Drug Schedule Mallinckrodt Inc., 3600 North Second
received. DEA has considered the Street, St. Louis, Missouri 63147, made
factors in 21 U.S.C. 823(a) and Hydromorphone (9150) ................ II application by renewal to the Drug
determined that the registration of Levo-alphacetylmethadol (9648) .. II Enforcement Administration (DEA) to
Johnson Matthey Inc. to manufacture Levorphanol(9220) ....................... II be registered as an importer of the basic
the listed basic class of controlled Meperidine (9230) ........................ II classes of controlled substances listed in
Methadone (9250) ........................ II
substance is consistent with the public schedule II:
Methadone intermediate (9254) ... II
interest at this time. DEA has Methamphetamine (1105) ............ II
investigated Johnson Matthey Inc. to Drug Schedule
Methylphenidate (1724) ................ II
ensure that the company’s registration is Metopon (9260) ............................ II
Phenylacetone (8501) .................. II
consistent with the public interest. The Morphine (9300) ........................... II Coca Leaves (9040) ..................... II
investigation has included inspection Opium extracts (9610) .................. II Opium, raw (9600) ....................... II
and testing of the company’s physical Opium fluid extract (9620) ............ II Poppy Straw (9650) ..................... II
security systems, verification of the Opium tincture (9630) .................. II Poppy Straw Concentrate (9670) II
company’s compliance with State and Opium, granulated (9640) ............ II
Opium, powdered (9639) ............. II
local laws, and a review of the The company plans to import the
Oxycodone (9143) ........................ II
company’s background and history. Oxymorphone (9652) ................... II listed controlled substances for the
Therefore, pursuant to 21 U.S.C. 823, Noroxymorphone (9668) .............. II manufacture of controlled substances in
and in accordance with 21 CFR 1301.33, Phenazocine (9715) ..................... II bulk for distribution to its customers.
the above named company is granted Alfentanil(9737) ............................ II No comments or objections have been
registration as a bulk manufacturer of Remifentanil (9739) ...................... II received. DEA has considered the
the basic class of controlled substance Sufentanil(9740) ........................... II factors in 21 U.S.C. 823(a) and 952(a)
listed. Thebaine (9333) ........................... II and determined that the registration of
Dated: May 9, 2007.
Mallinckrodt Inc. to import the basic
The firm plans to manufacture the classes of controlled substances is
Joseph T. Rannazzisi, listed controlled substances for internal consistent with the public interest and
Deputy Assistant Administrator, Office of use and for sale to other companies. with United States obligations under
Diversion Control, Drug Enforcement No comments or objections have been
Administration.
international treaties, conventions, or
received. DEA has considered the protocols in effect on May 1, 1971, at
[FR Doc. E7–9639 Filed 5–17–07; 8:45 am] factors in 21 U.S.C. 823(a) and this time. DEA has investigated
BILLING CODE 4410–09–P determined that the registration of Mallinckrodt Inc. to ensure that the
Mallinckrodt Inc. to manufacture the company’s registration is consistent
listed basic class of controlled substance with the public interest. The
DEPARTMENT OF JUSTICE is consistent with the public interest at investigation has included inspection
Drug Enforcement Administration this time. DEA has investigated and testing of the company’s physical
Mallinckrodt Inc. to ensure that the security systems, verification of the
Manufacturer of Controlled company’s registration is consistent company’s compliance with State and
Substances; Notice of Registration with the public interest. The local laws, and a review of the
investigation has included inspection company’s background and history.
By Notice dated January 23, 2007, and and testing of the company’s physical Therefore, pursuant to 21 U.S.C. 952(a)
published in the Federal Register on security systems, verification of the and 958(a), and in accordance with 21
January 30, 2007, (72 FR 4298), company’s compliance with State and CFR 1301.34, the above named company
Mallinckrodt Inc., 3600 North Second local laws, and a review of the is granted registration as an importer of
Street, St. Louis, Missouri 63147, made company’s background and history. the basic classes of controlled
application by renewal to the Drug Therefore, pursuant to 21 U.S.C. 823, substances listed.
Enforcement Administration (DEA) to and in accordance with 21 CFR 1301.33,
be registered as a bulk manufacturer of Dated: May 14, 2007.
the above named company is granted
the basic classes of controlled Joseph T. Rannazzisi,
registration as a bulk manufacturer of
substances listed in schedule I and II: the basic classes of controlled Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
substances listed.
Drug Schedule Administration.
Dated: May 14, 2007. [FR Doc. E7–9635 Filed 5–17–07; 8:45 am]
Codeine-N-oxide (9053) ............... I Joseph T. Rannazzisi, BILLING CODE 4410–09–P
Difenoxin (9168) ........................... I Deputy Assistant Administrator, Office of
Dihydromorphine (9145) ............... I Diversion Control, Drug Enforcement
Morphine-N-oxide (9307) ............. I Administration. DEPARTMENT OF JUSTICE
Norlevorphanol (9634) .................. I
[FR Doc. E7–9619 Filed 5–17–07; 8:45 am]
Normorphine (9313) ..................... I
BILLING CODE 4410–09–P Drug Enforcement Administration
Tetrahydrocannabinols (7370) ..... I
Nabilone (7379) ............................ II Manufacturer of Controlled
Alfentanil(9737) ............................ II
Amphetamine (1100) .................... II DEPARTMENT OF JUSTICE Substances; Notice of Registration
Ecgonine (9180) ........................... II By Notice dated August 15, 2006, and
Codeine (9050) ............................. II Drug Enforcement Administration published in the Federal Register on
Dextropropoxyphene, bulk(9273) II
August 22, 2006, (71 FR 48947),
pwalker on PROD1PC71 with NOTICES
Dihydrocodeine (9120) ................. II Importer of Controlled Substances;

Diphenoxylate (9170) ................... II Notice of Registration Noramco Inc., Division of Ortho-
Diprenorphine (9058) ................... II McNeil, Inc., 500 Old Swedes Landing
Etorphine HCL (9059) .................. II By Notice dated February 5, 2007 and Road, Wilmington, Delaware 19801,
Fentanyl(9801) ............................. II published in the Federal Register on made application by renewal, and by
Hydrocodone (9193) ..................... II February 12, 2007, (72 FR 6579), separate correspondence dated June 2,
VerDate Aug<31>2005 17:06 May 17, 2007 Jkt 211001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1
28076 Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices
2006, and July 25, 2006, to the Drug Inc., 1440 Olympic Drive, Athens,
Enforcement Administration (DEA) to Georgia 30601, made application by
be registered as a bulk manufacturer of letter to the Drug Enforcement Drug Schedule
the basic classes of controlled Administration (DEA) to be registered as
substances listed in schedule I and II: a bulk manufacturer of Methylphenidate Pentobarbital (2270) ..................... II
(1724), a basic class of controlled Hydrocodone (9193) ..................... II
Meperidine(9230) ......................... II
Drug Schedule substance listed in schedule II. Dextropropoxyphene (9273) ......... II
The company plans to bulk Fentanyl (9801) ............................ II
Codeine-N-Oxide (9053) .............. I manufacture methylphenidate for a
Morphine-N-Oxide (9307) ............. I customer to use in the production of a
Codeine (9050) ............................. II The company plans to manufacture
controlled substance product. bulk controlled substances for use in
Dihydrocodeine (9120) ................. II
No comments or objections have been product development and for
Oxycodone (9143) ........................ II
Dihydromorphine (9145) ............... II received. DEA has considered the distribution to its customers.
Hydrocodone (9193) ..................... II factors in 21 U.S.C. 823(a) and In reference to drug code 7360
Thebaine (9333) ........................... II determined that the registration of (Marihuana), the company plans to bulk
Morphine (9300) ........................... II Noramco Inc. to manufacture the listed manufacture cannabidiol as a synthetic
Oxymorphone (9652) ................... II basic class of controlled substance is intermediate. This controlled substance
consistent with the public interest at will be further synthesized to bulk
The company plans to bulk this time. DEA has investigated manufacture a synthetic THC (7370). No
manufacture the above listed controlled Noramco Inc. to ensure that the other activity for this drug code is
substances for sale and distribution to company’s registration is consistent authorized for this registration.
manufacturers for product development with the public interest. The No comments or objections have been
and formulation. investigation has included inspection received. DEA has considered the
By letter dated January 4, 2007, and testing of the company’s physical factors in 21 U.S.C. 823(a) and
Noramco has withdrawn their request security systems, verification of the determined that the registration of
for Amphetamine (1100) and company’s compliance with State and Organichem Corporation to manufacture
Methylphenidate (1724). local laws, and a review of the the listed basic classes of controlled
No comments or objections have been company’s background and history. substances is consistent with the public
received. DEA has considered the Therefore, pursuant to 21 U.S.C. 823, interest at this time. DEA has
factors in 21 U.S.C. 823(a) and and in accordance with 21 CFR 1301.33, investigated Organichem Corporation to
determined that the registration of the above named company is granted ensure that the company’s registration is
Noramco Inc. to manufacture the listed registration as a bulk manufacturer of consistent with the public interest. The
basic classes of controlled substances is the basic classes of controlled investigation has included inspection
consistent with the public interest at substances listed. and testing of the company’s physical
this time. DEA has investigated Dated: May 14, 2007. security systems, verification of the
Noramco Inc. to ensure that the Joseph T. Rannazzisi, company’s compliance with State and
company’s registration is consistent local laws, and a review of the
Deputy Assistant Administrator, Office of
with the public interest. The Diversion Control, Drug Enforcement company’s background and history.
investigation has included inspection Administration. Therefore, pursuant to 21 U.S.C. 823,
and testing of the company’s physical [FR Doc. E7–9651 Filed 5–17–07; 8:45 am] and in accordance with 21 CFR 1301.33,
security systems, verification of the BILLING CODE 4410–09–P the above named company is granted
company’s compliance with State and registration as a bulk manufacturer of
local laws, and a review of the the basic classes of controlled
company’s background and history. DEPARTMENT OF JUSTICE substances listed.
Therefore, pursuant to 21 U.S.C. 823,
Dated: May 14, 2007.
and in accordance with 21 CFR Drug Enforcement Administration
Joseph T. Rannazzisi,
1301.33(a), the above named company is
granted registration as a bulk Manufacturer of Controlled Deputy Assistant Administrator, Office of
Substances; Notice of Registration Diversion Control, Drug Enforcement
manufacturer of the basic classes of
Administration.
controlled substances listed. By Notice dated December 14, 2006, [FR Doc. E7–9612 Filed 5–17–07; 8:45 am]
Dated: May 8, 2007. and published in the Federal Register BILLING CODE 4410–09–P
Joseph T. Rannazzisi, on December 22, 2006, (71 FR 77066),
Deputy Assistant Administrator, Office of Organichem Corporation, 33 Riverside
Diversion Control, Drug Enforcement Avenue, Rensselaer, New York 12144, DEPARTMENT OF JUSTICE
Administration. made application by renewal to the
[FR Doc. E7–9631 Filed 5–17–07; 8:45 am] Drug Enforcement Administration Drug Enforcement Administration
BILLING CODE 4410–09–P (DEA) to be registered as a bulk
manufacturer of the basic classes of Manufacturer of Controlled
controlled substances listed in schedule Substances; Notice of Registration
DEPARTMENT OF JUSTICE I and II: By Notice dated January 16, 2007, and
published in the Federal Register on
Drug Enforcement Administration January 23, 2007, (72 FR 2907), Organix
Inc., 240 Salem Street, Woburn,
pwalker on PROD1PC71 with NOTICES
Manufacturer of Controlled Drug Schedule

Substances; Notice of Registration Massachusetts 01801, made application
Marihuana (7360) ......................... I by letter to the Drug Enforcement
By Notice dated July 26, 2006, and Tetrahydrocannabinols (7370) ..... I Administration (DEA) to be registered as
published in the Federal Register on Amphetamine (1100) .................... II a bulk manufacturer of
August 2, 2006, (71 FR 43814), Noramco Methylphenidate (1724) ................ II Tetrahydrocannabinols (7370), a basic
VerDate Aug<31>2005 17:06 May 17, 2007 Jkt 211001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1

Notice: Applications, Hearings, Determinations, Etc.: Noramco Inc.

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Notice: Applications, Hearings, Determinations, Etc.: Noramco Inc.

Uploaded by

Copyright:

Available Formats

Federal Register / Vol. 72, No.

96 / Friday, May 18, 2007 / Notices 28075

Dihydrocodeine (9120) ................. II Importer of Controlled Substances;

Manufacturer of Controlled Drug Schedule

You might also like